Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma.
Saved in:
| Title: | Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma. |
|---|---|
| Authors: | Corbett K; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Ruether D; Division of Oncology, Department of Medicine, University of Calgary, Calgary, AB, Canada., Seiden-Long I; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.; Alberta Precision Laboratories, Calgary, AB, Canada., Kline G; Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, 1820 Richmond Rd SW, Calgary, AB, T2T 5C7, Canada. gregory.kline@ahs.ca. |
| Source: | Calcified tissue international [Calcif Tissue Int] 2024 Apr; Vol. 114 (4), pp. 444-449. Date of Electronic Publication: 2024 Jan 22. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0827 (Electronic) Linking ISSN: 0171967X NLM ISO Abbreviation: Calcif Tissue Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
